Uncontrolled Asthma: Unmet Needs in the Management of Patients

References

• Armour C, Bosnic-Anticevich S, Brillant M, et al. Pharmacy asthma care program (PACP) improves outcomes for patients in the community. Thorax. 2007;62(6):496–502. doi:10.1136/thx.2006.064709
   PubMed Web of Science ®Google Scholar
• Bousquet J, Bousquet PJ, Godard P, et al. The public health implications of asthma. Bull WHO. 2005;83(7):548–554.
   PubMed Web of Science ®Google Scholar
• Wijnant SRA, Lahousse L, De Buyzere ML, et al. Prevalence of asthma and COPD and blood eosinophil count in a middle-aged Belgian population. J Clin Med. 2019;8(8):1122. doi:10.3390/jcm8081122
   Web of Science ®Google Scholar
• Eurostat. Respiratory disease statistics. Available from: http://ec.europa.eu/eurostat/statistics-explained/index.php/Respiratory_diseases_statistics. Accessed January, 2021.
   Google Scholar
• Selroos O, Kupczyk M, Kuna P, et al. National and regional asthma programmes in Europe. Eur Respir Rev. 2015;24(137):474–483. doi:10.1183/16000617.00008114
   PubMed Web of Science ®Google Scholar
• Caminati M, Senna G. Uncontrolled severe asthma: starting from the unmet needs. Curr Med Res Opin. 2019;35(2):175–177. doi:10.1080/03007995.2018.1528218
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO programmes and projects. Chronic respiratory diseases. Asthma. Available from: http://www.who.int/respiratory/asthma/en/. Accessed January, 2021.
   Google Scholar
• World Health Organization. WHO projections of mortality and burden of the disease 2004–2030. Available from: http://www.who.int/healthinfo/global/burden_disease/Dth6_2030.xls. Accessed January, 2021.
   Google Scholar
• Australian Centre for Asthma Monitoring. Health Care Expenditure and the Burden of Disease Due to Asthma in Australia. Canberra: Australian Institute of Health and Welfare; 2005:43.
   Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Available from: https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf. Accessed December, 2020.
   Google Scholar
• Vianello A, Caminati M, Crivellaro M, et al. Fatal asthma; is it still an epidemic? World Allergy Organ J. 2016;9(1):42. doi:10.1186/s40413-016-0129-9
   Web of Science ®Google Scholar
• Horne R, Price D, Cleland J, et al. Can asthma control be improved by understanding the patient’s perspective? BMC Pulm Med. 2007;7:8. doi:10.1186/1471-2466-7-8
   PubMedGoogle Scholar
• Rabe KF, Vermeire PA, Soriano JB, et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000;16(5):802–807. doi:10.1183/09031936.00.16580200
   PubMed Web of Science ®Google Scholar
• Van Ganse E, Boissel JP, Gormand F, et al. Level of control and hospital contacts in persistent asthma. J Asthma. 2001;38(8):637–643. doi:10.1081/JAS-100107541
   PubMed Web of Science ®Google Scholar
• Van Ganse E, Laforest L, Pietri G, et al. Persistent asthma: disease control, resource utilisation and direct costs. Eur Respir J. 2002;20(2):260–267. doi:10.1183/09031936.02.02542001
   PubMed Web of Science ®Google Scholar
• Busse W, Fang J, Marvel J, et al. Uncontrolled asthma across GINA treatment steps 2 − 5 in a large US patient cohort. J Asthma. 2021;12:1–15. doi:10.1080/02770903.2021.1897834
   Web of Science ®Google Scholar
• Senna G, Caminati M, Lockey RF. Allergen immunotherapy adherence in the real world: how bad is it and how can it be improved? Curr Treat Options Allergy. 2015;2(1):39–53. doi:10.1007/s40521-014-0037-6
   Google Scholar
• Hardtstock F, Maywald U, Timmermann H, et al. Extent of non-adherence and non-persistence in asthma patients: analysis of a large claims data set. J Asthma. 2021;20:1–11. doi:10.1080/02770903.2021.1871738
   Web of Science ®Google Scholar
• Wroe A. Intentional and unintentional nonadherence: a study of decision making. J Behav Med. 2002;25(4):355–372. doi:10.1023/A:1015866415552
   PubMed Web of Science ®Google Scholar
• George M. Adherence in asthma and COPD: new strategies for an old problem. Respir Care. 2018;63(6):818–831. doi:10.4187/respcare.05905
   PubMed Web of Science ®Google Scholar
• Lavorini F, Janson C, Braido F, et al. What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape. Ther Adv Respir Dis. 2019;13:1753466619884532. doi:10.1177/1753466619884532
   Web of Science ®Google Scholar
• Aydın MR, Aydemir Y, Aydın A, et al. The effect of video presentation showed in the outpatient clinic waiting area on the success of inhaler device use in chronic respiratory diseases. Heart Lung. 2021;50(2):323–328. doi:10.1016/j.hrtlng.2021.01.009
   Web of Science ®Google Scholar
• Magnoni MS, Caminati M, Senna G, et al. Asthma under/misdiagnosis in primary care setting: an observational community-based study in Italy. Clin Mol Allergy. 2015;13(1):26. doi:10.1186/s12948-015-0032-x
   PubMedGoogle Scholar
• Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis. Nat Rev Dis Primers. 2020;6(1):95. doi:10.1038/s41572-020-00227-0
   PubMed Web of Science ®Google Scholar
• Tiotiu A, Ioan I, Wirth N, et al. The impact of tobacco smoking on adult asthma outcomes. Int J Environ Res Public Health. 2021;18(3):992. doi:10.3390/ijerph18030992
   PubMed Web of Science ®Google Scholar
• Boulet LP, Boulay ME, Coxson HO, et al. Asthma with irreversible airway obstruction in smokers and nonsmokers: links between airway inflammation and structural changes. Respiration. 2020;8:1–11.
   Google Scholar
• Harrold LR, Field TS, Gurwitz JH. Knowledge, patterns of care, and outcomes of care for generalists and specialists. J Gen Intern Med. 1999;14(8):499–511. doi:10.1046/j.1525-1497.1999.08168.x
   PubMed Web of Science ®Google Scholar
• de Marco R, Cazzoletti L, Cerveri I, et al; ISAYA Study Group. Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma. Int Arch Allergy Immunol. 138;2005:225–234. doi:10.1159/000088723
   PubMed Web of Science ®Google Scholar
• Braido F, Baiardini I, Alleri P, et al. Asthma management in a specialist setting: results of an Italian respirtory society survey. Pulm Pharmacol Ther. 2017;44:83–87. doi:10.1016/j.pupt.2017.03.013
   PubMed Web of Science ®Google Scholar
• Cloutier M, Akinbami L, Salo P, et al. Use of national asthma guidelines by allergists and pulmonologists: a national survey. J Allergy Clin Immunol Pract. 2020;8(9):3011–3020.e2. doi:10.1016/j.jaip.2020.04.026
   PubMed Web of Science ®Google Scholar
• Caminati M, Vianello A, Ricci G, et al. Trends and determinants of emergency room admissions for asthma: a retrospective evaluation in Northeast Italy. World Allergy Organ J. 2019;12(7):100046. doi:10.1016/j.waojou.2019.100046
   PubMed Web of Science ®Google Scholar
• Suruki RY, Daugherty JB, Boudiaf N, et al. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA. BMC Pulm Med. 2017;17(1):74. doi:10.1186/s12890-017-0409-3
   PubMed Web of Science ®Google Scholar
• Al-Jahdali H, Anwar A, Al-Harbi A. Factors associated with patient visits to the emergency department for asthma therapy. BMC Pulm Med. 2012;12:80. doi:10.1186/1471-2466-12-80
   PubMed Web of Science ®Google Scholar
• Pola-Bibian B, Dominguez-Ortega J, Vilà-Nadal G. Predictors of asthma relapse in patients who attended an emergency department. Allergy Asthma Proc. 2018;39(4):292–298. doi:10.2500/aap.2018.39.4130
   Web of Science ®Google Scholar
• Senna G, Caminati M, Bovo C, et al. The role of the pharmacy in the management of bronchial asthma: a literature-based evaluation. Ann Allergy Asthma Immunol. 2017;118(2):161–165. doi:10.1016/j.anai.2016.10.019
   PubMed Web of Science ®Google Scholar
• Caminati M, Cegolon L, Bacchini M, et al. The potential role of local pharmacies to assess asthma control: an Italian cross-sectional study. BMC Public Health. 2021;21(1):19. doi:10.1186/s12889-020-10080-1
   Web of Science ®Google Scholar
• Hedenrud T, Jakobsson A, El Malla H, et al. “I did not know it was so important to take it the whole time” - self-reported barriers to medical treatment among individuals with asthma. BMC Pulm Med. 2019;19(1):175. doi:10.1186/s12890-019-0934-3
   Web of Science ®Google Scholar
• Baiardini I, Novakova S, Mihaicuta S, et al. Adherence to treatment in allergic respiratory diseases. Expert Rev Respir Med. 2019;13(1):53–62. doi:10.1080/17476348.2019.1554438
   PubMed Web of Science ®Google Scholar
• De Keyser HH, Ramsey R, Federico MJ. They just don’t take their medicines: reframing medication adherence in asthma from frustration to opportunity. Pediatr Pulmonol. 2020;55(3):818–825. doi:10.1002/ppul.24643
   PubMed Web of Science ®Google Scholar
• Gruffydd-Jones K, Hansen K. Working for better asthma control: how can we improve the dialogue between patients and healthcare professionals? Adv Ther. 2020;37(1):1–9. doi:10.1007/s12325-019-01131-0
   PubMed Web of Science ®Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.00202013
   PubMed Web of Science ®Google Scholar
• Caminati M, Vianello A, Andretta M, et al. Low adherence to inhaled corticosteroids/long-acting beta(2)-agonists and biologic treatment in severe asthmatics. ERJ Open Res. 2020;6(2):00017–2020. doi:10.1183/23120541.00017-2020
   PubMedGoogle Scholar
• d’Ancona G, Kavanagh J, Roxas C, et al. Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma. Eur Respir J. 2020;55(5):1902259. doi:10.1183/13993003.02259-2019
   PubMed Web of Science ®Google Scholar
• Hinks TSC, Levine SJ, Brusselle GG. Treatment options in type-2 low asthma. Eur Respir J. 2021;57(1):2000528. doi:10.1183/13993003.00528-2020
   PubMed Web of Science ®Google Scholar
• Lee J, An J, Won H, et al. Prevalence and impact of comorbid laryngeal dysfunction in asthma: a systematic review and meta-analysis. J Allergy Clin Immunol. 2020;145(4):1165–1173. doi:10.1016/j.jaci.2019.12.906
   PubMed Web of Science ®Google Scholar
• Vertigan AE, Kapela SL, Gibson PG. Laryngeal dysfunction in severe asthma: a Cross-Sectional Observational Study. J Allergy Clin Immunol Pract. 2021;9(2):897–905. doi:10.1016/j.jaip.2020.09.034
   Web of Science ®Google Scholar
• Caminati M, Pham DL, Bagnasco D, et al. Type 2 immunity in asthma. World Allergy Organ J. 2018;11(1):13. doi:10.1186/s40413-018-0192-5
   PubMed Web of Science ®Google Scholar
• Ntontsi P, Samitas K, Zervas E, et al. Severe asthma: what is new in the new millennium. Curr Opin Allergy Clin Immunol. 2020;20(2):202–207. doi:10.1097/ACI.0000000000000623
   PubMed Web of Science ®Google Scholar
• Jackson D, Busby J, Pfeffer P, et al. UK severe asthma registry. Characterisation of patients with severe asthma in the UK severe asthma registry in the biologic era. Thorax. 2021;76(3):220–227. doi:10.1136/thoraxjnl-2020-215168
   PubMed Web of Science ®Google Scholar
• Kupczyk M, Dahlén B, Sterk PJ, et al. BIOAIR investigators stability of phenotypes defined by physiological variables and biomarkers in adults with asthma. Allergy. 2014;69(9):1198–1204. doi:10.1111/all.12445
   PubMed Web of Science ®Google Scholar
• Caminati M, Bagnasco D, Rosenwasser LJ, et al. Biologics for the treatments of allergic conditions: severe asthma. Immunol Allergy Clin North Am. 2020;40(4):549–564. doi:10.1016/j.iac.2020.07.003
   Web of Science ®Google Scholar
• Hartl S, Breyer MK, Burghuber OC, et al. Blood eosinophil count in the general population: typical values and potential confounders. Eur Respir J. 2020;55(5):1901874. doi:10.1183/13993003.01874-2019
   PubMed Web of Science ®Google Scholar
• Pepper A, Hanania N, Humbert M, et al. How to assess effectiveness of biologics for asthma and what steps to take when there is not benefit. J Allergy Clin Immunol Pract. 2021;9(3):1081–1088. doi:10.1016/j.jaip.2020.10.048
   PubMed Web of Science ®Google Scholar
• Ulrik C, Lange P, Hilbergc O. Fractional exhaled nitric oxide as a determinant for the clinical course of asthma: a systematic review. Eur Clin Respir J. 2021;8(1):1891725. doi:10.1080/20018525.2021.1891725
   Web of Science ®Google Scholar
• Diamant Z, Vijverberg S, Alving K, et al. Toward clinically applicable biomarkers for asthma: an EAACI position paper. Allergy. 2019;74(10):1835–1851. doi:10.1111/all.13806
   PubMed Web of Science ®Google Scholar
• Tran T, King E, Sarkar Nan C, et al. Oral corticosteroid prescription for France, Germany, Italy and UK. Eur Res J. 2020;55(6):1902363. doi:10.1183/13993003.02363-2019
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Duh M, Lafeuille M, et al. Burden of systemic glucocorticoid-related complications in severe asthma. Curr Med Res Opin. 2017;33(1):57–65. doi:10.1080/03007995.2016.1233101
   PubMed Web of Science ®Google Scholar
• Rogliani P, Ritondo B, Puxeddu E, et al. Experimental glucocorticoid receptor agonists for the treatment of asthma: a systematic review. J Exp Pharmacol. 2020;12:233–254. doi:10.2147/JEP.S237480
   PubMedGoogle Scholar
• Maijers I, Kearns N, Harper J, et al. Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma. Eur Respir J. 2020;55(1):1901147. doi:10.1183/13993003.01147-2019
   PubMed Web of Science ®Google Scholar
• Caminati M, Morais-Almeida M, Bleecker E, et al. Biologics and global burden of asthma: a worldwide portrait and a call for action. World Allergy Organ J. 2021;14(2):100502. doi:10.1016/j.waojou.2020.100502
   PubMed Web of Science ®Google Scholar
• Menzella F, Bertolini F, Biava M, et al. Severe refractory asthma: current treatment options and ongoing research. Drugs Context. 2018;7:212561. doi:10.7573/dic.212561
   PubMedGoogle Scholar
• Narendra D, Blixt J, Hanania NA. Immunological biomarkers in severe asthma. Semin Immunol. 2019;46:101332. doi:10.1016/j.smim.2019.101332
   PubMed Web of Science ®Google Scholar
• Holguin F, Cardet JC, Chung KF, et al. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2020;55(1):1900588. doi:10.1183/13993003.00588-2019
   PubMed Web of Science ®Google Scholar
• Olivieri B, Tinazzi E, Caminati M, et al. Biologics for the treatment of allergic conditions: eosinophil disorders. Immunol Allergy Clin North Am. 2020;40(4):649–665. doi:10.1016/j.iac.2020.07.001
   PubMed Web of Science ®Google Scholar
• Oh H, Rizo C, Enkin M, Jadad A, Powell J, Pagliari C. What is eHealth (3): a systematic review of published definitions. J Med Internet Res. 2005;7(1). doi:10.2196/jmir.7.1.e1
   Web of Science ®Google Scholar
• Bonini M. Electronic health (e-health): emerging role in asthma. Curr Opin Pulm Med. 2017;23(1):21–26. doi:10.1097/MCP.0000000000000336
   PubMed Web of Science ®Google Scholar
• Berlinski A, Chervinskiy SK, Simmons AL, et al. Delivery of high-quality pediatrics pirometry in rural communities: a novel use for telemedicine. J Allergy Clin Immunol Pract. 2018;6(3):1042–1044. doi:10.1016/j.jaip.2018.01.032
   Web of Science ®Google Scholar
• Persaud YK, Portnoy JM. Ten rules for implementation of a telemedicine program to care for patients with asthma. J Allergy Clin Immunol Pract. 2021;9(1):13–21. doi:10.1016/j.jaip.2020.10.005
   PubMed Web of Science ®Google Scholar
• Snoswell CL, Rahja M, Lalor AF. A systematic review and meta-analysis of change in health-related quality of life for interactive telehealth interventions for patients with asthma. Value Health. 2021;24(2):291–302. doi:10.1016/j.jval.2020.09.006
   Web of Science ®Google Scholar
• Poowuttikul P, Seth D. New concepts and technological resources in patient education and asthma self-management. Clin Rev Allergy Immunol. 2020;59(1):19–37. doi:10.1007/s12016-020-08782-w
   Web of Science ®Google Scholar
• Nguyen E, Miao B, Pugliese N, et al. Systematic review of mHealth applications that interface with inhaler sensors in asthma. J Allergy Clin Immunol Pract. 2021;9(2):SS2213–8. doi:10.1016/j.jaip.2020.08.049
   Web of Science ®Google Scholar
• Brown W, Odenthal D. The uses of telemedicine to improve asthma control. J Allergy Clin Immunol Pract. 2015;3(2):300–301. doi:10.1016/j.jaip.2014.10.003
   PubMed Web of Science ®Google Scholar
• Portnoy JM, Waller M, De Lurgio S, et al. Telemedicine is as effective as in-person visits for patients with asthma. Ann Allergy Asthma Immunol. 2016;117(3):241–245. doi:10.1016/j.anai.2016.07.012
   PubMed Web of Science ®Google Scholar
• Rasmussen LM, Phanareth K, Nolte H, et al. Internet-based monitoring of asthma: a long-term, randomized clinical study of 300 asthmatic subjects. J Allergy Clin Immunol. 2005;115(6):1137–1142. doi:10.1016/j.jaci.2005.03.030
   PubMed Web of Science ®Google Scholar
• Lin NY, Ramsey RR, Miller JL, et al. Telehealth delivery of adherence and medication management system improves outcomes in inner-city children with asthma. Pediatr Pulmonol. 2020;55(4):858–865. doi:10.1002/ppul.24623
   Web of Science ®Google Scholar
• Mosnaim GS, Stempel DA, Gonzalez C, et al. The impact of patient self-monitoring via electronic medication monitor and mobile app plus remote clinician feedback on adherence to inhaled corticosteroids: a randomized controlled trial. J Allergy Clin Immunol Pract. 2020:S2213-2198(20)31220–4.
   Web of Science ®Google Scholar
• Huckvale K, Morrison C, Ouyang J, et al. The evolution of mobile apps for asthma: an updated systematic assessment of content and tools. BMC Med. 2015;13(1):1–15. doi:10.1186/s12916-015-0303-x
   Web of Science ®Google Scholar